$SBRA
Sabra Health Care REIT, Inc.

2021 Q1 Form 10-Q Financial Statement

#000149229821000025 Filed on May 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $152.4M $149.3M
YoY Change 2.02% 9.19%
Cost Of Revenue $28.60M $27.00M
YoY Change 5.93% 125.0%
Gross Profit $123.7M $122.4M
YoY Change 1.06% -1.84%
Gross Profit Margin 81.19% 81.96%
Selling, General & Admin $11.00M $9.300M
YoY Change 18.28% -1.06%
% of Gross Profit 8.89% 7.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $44.38M $44.17M
YoY Change 0.47% -1.74%
% of Gross Profit 35.87% 36.08%
Operating Expenses $60.60M $58.30M
YoY Change 3.95% -2.35%
Operating Profit $63.10M $64.10M
YoY Change -1.56% -1.38%
Interest Expense -$29.00M -$28.90M
YoY Change 0.35% -23.34%
% of Operating Profit -45.96% -45.09%
Other Income/Expense, Net $653.0K $2.042M
YoY Change -68.02% -251.37%
Pretax Income $39.16M $39.93M
YoY Change -1.93% -152.74%
Income Tax $700.0K $1.042M
% Of Pretax Income 1.79% 2.61%
Net Earnings $33.45M $35.20M
YoY Change -4.98% -145.3%
Net Earnings / Revenue 21.95% 23.57%
Basic Earnings Per Share $0.16 $0.17
Diluted Earnings Per Share $0.16 $0.17
COMMON SHARES
Basic Shares Outstanding 211.5M shares 205.4M shares
Diluted Shares Outstanding 212.6M shares 206.0M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.90M $54.10M
YoY Change -53.97% 136.24%
Cash & Equivalents $24.88M $54.05M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $213.4M $215.9M
YoY Change -1.16% 52.04%
LONG-TERM ASSETS
Property, Plant & Equipment $5.279B $5.363B
YoY Change -1.56% -1.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $283.8M $311.8M
YoY Change -8.98% -7.13%
Other Assets $4.600M $8.400M
YoY Change -45.24% -97.01%
Total Long-Term Assets $5.750B $5.876B
YoY Change -2.14% -6.92%
TOTAL ASSETS
Total Short-Term Assets $213.4M $215.9M
Total Long-Term Assets $5.750B $5.876B
Total Assets $5.964B $6.092B
YoY Change -2.11% -5.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $105.9M $112.5M
YoY Change -5.87% 54.32%
Accrued Expenses $17.60M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $123.5M $112.5M
YoY Change 9.78% 35.71%
LONG-TERM LIABILITIES
Long-Term Debt $2.282B $2.479B
YoY Change -7.97% -23.25%
Other Long-Term Liabilities $55.40M $105.2M
YoY Change -47.34% 15.22%
Total Long-Term Liabilities $2.337B $2.585B
YoY Change -9.58% -22.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $123.5M $112.5M
Total Long-Term Liabilities $2.337B $2.585B
Total Liabilities $2.460B $2.697B
YoY Change -8.77% -20.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.159M $2.056M
YoY Change 5.01% 15.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.503B $3.395B
YoY Change
Total Liabilities & Shareholders Equity $5.964B $6.092B
YoY Change -2.11% -5.62%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $33.45M $35.20M
YoY Change -4.98% -145.3%
Depreciation, Depletion And Amortization $44.38M $44.17M
YoY Change 0.47% -1.74%
Cash From Operating Activities $68.53M $74.82M
YoY Change -8.4% 38.66%
INVESTING ACTIVITIES
Capital Expenditures -$28.70M -$67.30M
YoY Change -57.36%
Acquisitions
YoY Change
Other Investing Activities -$6.700M -$2.600M
YoY Change 157.69% -141.27%
Cash From Investing Activities -$35.36M -$69.82M
YoY Change -49.36% -1200.11%
FINANCING ACTIVITIES
Cash Dividend Paid $63.22M $92.39M
YoY Change -31.57% 15.11%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$69.28M $8.948M
YoY Change -874.21% -110.23%
NET CHANGE
Cash From Operating Activities $68.53M $74.82M
Cash From Investing Activities -$35.36M -$69.82M
Cash From Financing Activities -$69.28M $8.948M
Net Change In Cash -$36.10M $13.94M
YoY Change -358.92% -151.32%
FREE CASH FLOW
Cash From Operating Activities $68.53M $74.82M
Capital Expenditures -$28.70M -$67.30M
Free Cash Flow $97.23M $142.1M
YoY Change -31.58% 163.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001492298
CY2021Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
sbra:ResidentFeesAndServicesMember
CY2020Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
sbra:ResidentFeesAndServicesMember
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-34950
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
SABRA HEALTH CARE REIT, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2560479
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
18500 Von Karman Avenue, Suite 550
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2021Q1 dei City Area Code
CityAreaCode
888
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
393-8248
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock, $.01 par value
CY2021Q1 dei Trading Symbol
TradingSymbol
SBRA
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
215930202 shares
CY2021Q1 us-gaap Assets
Assets
5963838000 USD
CY2020Q4 us-gaap Assets
Assets
5985603000 USD
CY2021Q1 us-gaap Secured Debt
SecuredDebt
78562000 USD
CY2021Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
723919000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2021Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5279443000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q1 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
101225000 USD
CY2020Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
102839000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
283751000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
288761000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24878000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59076000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4609000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6447000 USD
CY2021Q1 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
81451000 USD
CY2020Q4 sbra Finite Lived Intangible Assets Leases Net
FiniteLivedIntangibleAssetsLeasesNet
82796000 USD
CY2021Q1 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
188481000 USD
CY2020Q4 sbra Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net
AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
160646000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
79065000 USD
CY2021Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
954552000 USD
CY2020Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
1044916000 USD
CY2021Q1 us-gaap Unsecured Debt
UnsecuredDebt
1248464000 USD
CY2020Q4 us-gaap Unsecured Debt
UnsecuredDebt
1248393000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
123505000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
146276000 USD
CY2021Q1 us-gaap Below Market Lease Net
BelowMarketLeaseNet
55351000 USD
CY2020Q4 us-gaap Below Market Lease Net
BelowMarketLeaseNet
57725000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
2460434000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2576375000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
215930202 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
215930202 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
210560815 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
210560815 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
2159000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2106000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4254134000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4163228000 USD
CY2021Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
746516000 USD
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
716195000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6373000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39911000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3503404000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3409228000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5963838000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5985603000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
113383000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
106512000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2941000 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
2851000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36041000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39983000 USD
CY2021Q1 us-gaap Revenues
Revenues
152365000 USD
CY2020Q1 us-gaap Revenues
Revenues
149346000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44375000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44168000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
24443000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25704000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8938000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8761000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2025000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
667000 USD
CY2021Q1 sbra Operating And Interest Expense
OperatingAndInterestExpense
113861000 USD
CY2020Q1 sbra Operating And Interest Expense
OperatingAndInterestExpense
111462000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-793000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
133000 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2259000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1313000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-217000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
653000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2042000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39157000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39926000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5010000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3667000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1042000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
33447000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
33538000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38985000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211450699 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205395330 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212624305 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206006285 shares
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
33447000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-251000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1707000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
33789000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-40692000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66985000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3768000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3488460000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38985000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2988000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
718000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
93018000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3395213000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3409228000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
33447000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
33538000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2835000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
88124000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
63768000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3503404000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
33447000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
35217000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44375000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44168000 USD
CY2021Q1 sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-5713000 USD
CY2020Q1 sbra Non Cash Rental And Related Revenues Adjustments
NonCashRentalAndRelatedRevenuesAdjustments
-365000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
412000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
561000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1896000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2233000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2288000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2360000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-793000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2025000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
667000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
1313000 USD
CY2020Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-217000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5010000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3667000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4040000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2873000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6895000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10992000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9929000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68531000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74819000 USD
CY2021Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
28654000 USD
CY2020Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
67274000 USD
CY2021Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
CY2020Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
936000 USD
CY2021Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
10833000 USD
CY2020Q1 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
11956000 USD
CY2021Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
628000 USD
CY2020Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1011000 USD
CY2021Q1 sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-301000 USD
CY2020Q1 sbra Repayments Of Preferred Equity Investments
RepaymentsOfPreferredEquityInvestments
-3059000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3202000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
6272000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35356000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69824000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
101000000 USD
CY2021Q1 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
93000000 USD
CY2020Q1 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
0 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
709000 USD
CY2020Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
877000 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2020Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
715000 USD
CY2021Q1 sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
87654000 USD
CY2020Q1 sbra Proceeds Payments From Issuance Of Stock Net Of Taxes Paid On Behalf Of Employees
ProceedsPaymentsFromIssuanceOfStockNetOfTaxesPaidOnBehalfOfEmployees
1930000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
63221000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
92390000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-69276000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8948000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-36101000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13943000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-660000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65523000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49143000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29487000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62426000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
21620000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
21526000 USD
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 USD
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
16092000 USD
CY2021Q1 sbra Real Estate Investments Joint Ventures Number
RealEstateInvestmentsJointVenturesNumber
0 investment
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2021Q1 us-gaap Land
Land
594649000 USD
CY2020Q4 us-gaap Land
Land
594843000 USD
CY2021Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6003362000 USD
CY2021Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
723919000 USD
CY2021Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5279443000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5966695000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5153257000 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5120598000 USD
CY2021Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
252563000 USD
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
249034000 USD
CY2021Q1 us-gaap Land Improvements
LandImprovements
2893000 USD
CY2020Q4 us-gaap Land Improvements
LandImprovements
2220000 USD
CY2021Q1 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16300000 USD
CY2021Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6003362000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5966695000 USD
CY2021Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
723919000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
681657000 USD
CY2021Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5279443000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5285038000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2021Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
12600000 USD
CY2020Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
17500000 USD
CY2021Q1 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
91000000 USD
CY2020Q4 sbra Letters Of Credit Deposits
LettersOfCreditDeposits
85000000 USD
CY2020Q4 sbra Property Taxes Insurance And Tenant Improvement Deposit Liability
PropertyTaxesInsuranceAndTenantImprovementDepositLiability
16900000 USD
CY2021Q1 us-gaap Variable Lease Income
VariableLeaseIncome
4800000 USD
CY2020Q1 us-gaap Variable Lease Income
VariableLeaseIncome
5200000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
325343000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
417966000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
407895000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
408876000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
399770000 USD
CY2021Q1 sbra Lessor Operating Lease Payment To Be Received After Year Four
LessorOperatingLeasePaymentToBeReceivedAfterYearFour
1572014000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
3531864000 USD
CY2021Q1 sbra Financing Receivable Numberof Loans
FinancingReceivableNumberofLoans
18 loan
CY2021Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
64692000 USD
CY2021Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
60722000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
61357000 USD
CY2021Q1 sbra Financing Receivable Fixed Interest Rate
FinancingReceivableFixedInterestRate
0.078
CY2021Q1 sbra Financing Receivable Effective Interest Rate
FinancingReceivableEffectiveInterestRate
0.079
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4358000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2458000 USD
CY2021Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
64692000 USD
CY2021Q1 us-gaap Notes Receivable Net
NotesReceivableNet
56364000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
58899000 USD
CY2021Q1 sbra Preferred Equity Investments Number
PreferredEquityInvestmentsNumber
6 preferredEquityInvestment
CY2021Q1 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
44634000 USD
CY2021Q1 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
44861000 USD
CY2020Q4 sbra Preferred Equity Investment Carrying Amount
PreferredEquityInvestmentCarryingAmount
43940000 USD
CY2021Q1 sbra Preferred Equity Investment Weighted Average Contractual Rate
PreferredEquityInvestmentWeightedAverageContractualRate
0.113
CY2021Q1 sbra Preferred Equity Investment Weighted Average Effective Rate
PreferredEquityInvestmentWeightedAverageEffectiveRate
0.113
CY2021Q1 sbra Numberof Investments
NumberofInvestments
24 investment
CY2021Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
109326000 USD
CY2021Q1 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
101225000 USD
CY2020Q4 sbra Financing Receivable And Other Investments Net
FinancingReceivableAndOtherInvestmentsNet
102839000 USD
CY2021Q1 sbra Investments Weighted Average Contractual Rate
InvestmentsWeightedAverageContractualRate
0.092
CY2021Q1 sbra Investments Weighted Average Effective Rate
InvestmentsWeightedAverageEffectiveRate
0.093
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1900000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
700000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4400000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
24400000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25700000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1900000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2200000 USD
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
17600000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16100000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
17902000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
14412000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
352478000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
901820000 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2615000 USD
CY2021Q1 sbra Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1001730000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2290957000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-6140000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15519000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
2281578000 USD
CY2021Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
25907000 USD
CY2021Q1 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
9513000 USD
CY2021Q1 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
28868000 USD
CY2020Q1 sbra Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-28475000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
34415000 USD
CY2021Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2021Q1 us-gaap Derivative Assets
DerivativeAssets
34415000 USD
CY2021Q1 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
9513000 USD
CY2021Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
24902000 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
25907000 USD
CY2021Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2021Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
16394000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
12802000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0 USD
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
12802000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
7420000 USD
CY2020Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
5382000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
37018000 USD
CY2020Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
37018000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
7420000 USD
CY2020Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
29598000 USD
CY2021Q1 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
64692000 USD
CY2020Q4 sbra Financing Receivable Principal Amount
FinancingReceivablePrincipalAmount
65320000 USD
CY2021Q1 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
44634000 USD
CY2020Q4 sbra Preferred Equity Investment Face Value
PreferredEquityInvestmentFaceValue
43724000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1900000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
900000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33447000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35217000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211450699 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
205395330 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212624305 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206006285 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17

Files In Submission

Name View Source Status
0001492298-21-000025-index-headers.html Edgar Link pending
0001492298-21-000025-index.html Edgar Link pending
0001492298-21-000025.txt Edgar Link pending
0001492298-21-000025-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
sbra-20210331.htm Edgar Link pending
sbra-20210331.xsd Edgar Link pending
sbra-20210331_cal.xml Edgar Link unprocessable
sbra-20210331_def.xml Edgar Link unprocessable
sbra-20210331_htm.xml Edgar Link completed
sbra-20210331_lab.xml Edgar Link unprocessable
sbra-20210331_pre.xml Edgar Link unprocessable
sbraex3112021q1.htm Edgar Link pending
sbraex3122021q1.htm Edgar Link pending
sbraex3212021q1.htm Edgar Link pending
sbraex3222021q1.htm Edgar Link pending
Show.js Edgar Link pending